General Information of Drug Transporter (DT)
DT ID DTD0342 Transporter Info
Gene Name SLC39A14
Transporter Name Zinc transporter ZIP14
Gene ID
23516
UniProt ID
Q15043
Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota

   Genus: Corynebacterium

     Corynebacterium diphtheriae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [2] , [3] , [4]

Regulating Factor

Corynebactin

Detailed Description

The compound Corynebactin Secreted by Corynebacterium diphtheriae C7 (beta) has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Mycobacterium

     Mycobacterium avium 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [3] , [4]

Regulating Factor

Carboxymycobactin

Detailed Description

The compound Carboxymycobactin Secreted by Mycobacterium avium CRl/69 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Mycobacterium tuberculosis 

Microbe Info

Click to Show/Hide the Full List 8 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [7]

Regulating Factor

Desferriexochelin 772MS

Detailed Description

The compound Desferriexochelin 772MS Secreted by Mycobacterium tuberculosis str. Erdman has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [3] , [4]

Regulating Factor

desA1

Detailed Description

The protein desA1 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [3] , [4]

Regulating Factor

GAPDH

Detailed Description

The protein GAPDH of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Co-transport of human SLC39A14 substrates/drugs in the health condition [6] , [8] , [4]

Regulating Factor

IrtAB ,

Detailed Description

The protein IrtAB of Mycobacterium tuberculosis H37Rv has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [3] , [4]

Regulating Factor

Rv0641

Detailed Description

The protein Rv0641 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 6

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [3] , [4]

Regulating Factor

Rv0704

Detailed Description

The protein Rv0704 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 7

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [3] , [4]

Regulating Factor

Rv1872c

Detailed Description

The protein Rv1872c of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 8

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [3] , [4]

Regulating Factor

tuf

Detailed Description

The protein tuf of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Mycolicibacterium

     Mycolicibacterium vaccae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [9]

Regulating Factor

Exochelin 772SM

Detailed Description

The compound Exochelin 772SM Secreted by Mycolicibacterium vaccae R877R has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

Bacteria: Bacillota

   Genus: Bacillus

     Bacillus anthracis 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [10] , [11] , [12]

Regulating Factor

Corynebactin

Detailed Description

The compound Corynebactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [10] , [11] , [12]

Regulating Factor

Petrobactin

Detailed Description

The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [13] , [14] , [3] , [4]

Regulating Factor

Petrobactin

Detailed Description

The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Bacillus cereus 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [10] , [11] , [12]

Regulating Factor

Corynebactin

Detailed Description

The compound Corynebactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [10] , [11] , [12]

Regulating Factor

Petrobactin

Detailed Description

The compound Petrobactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Bacillus subtilis 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [16] , [17] , [18]

Regulating Factor

ycdH

Detailed Description

The protein ycdH of Bacillus subtilis ZB307A has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [16] , [17] , [18]

Regulating Factor

yciC

Detailed Description

The protein yciC of Bacillus subtilis ZB307A has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Bacillus thuringiensis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [10] , [11] , [12]

Regulating Factor

Corynebactin

Detailed Description

The compound Corynebactin Secreted by Bacillus thuringiensis ATCC 33679 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Lactococcus

     Lactococcus lactis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [19] , [20]

Regulating Factor

ZitSQP , ,

Detailed Description

The protein ZitSQP of Lactococcus lactis subsp. lactis Il1403 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Listeria

     Listeria monocytogenes 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [21]

Regulating Factor

zinA

Studied Tissue

Uterus

In Vivo Model

MF1 mice

In Vitro Model

Human papillomavirus-related endocervical adenocarcinoma cells (HeLa M)

Detailed Description

The protein zinA of Listeria monocytogenes EGD-e has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [21]

Regulating Factor

ZurAM ,

Studied Tissue

Uterus

In Vivo Model

MF1 mice

In Vitro Model

Human papillomavirus-related endocervical adenocarcinoma cells (HeLa M)

Detailed Description

The protein ZurAM of Listeria monocytogenes EGD-e has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Staphylococcus

     Staphylococcus aureus 

Microbe Info

Click to Show/Hide the Full List 16 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [22] , [3] , [4]

Regulating Factor

Aureochelin

Detailed Description

The compound aureochelin secreted by Staphylococcus aureus has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [23] , [3] , [4]

Regulating Factor

Staphyloferrin A

Detailed Description

The compound Staphyloferrin A Secreted by Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [24] , [3] , [4]

Regulating Factor

Staphylopine

Detailed Description

The compound Staphylopine Secreted by Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [25] , [26] , [27]

Regulating Factor

CzrA

Detailed Description

The protein czra of Staphylococcus aureus has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 5

Co-transport of human SLC39A14 substrates/drugs in the health condition [28] , [29] , [4]

Regulating Factor

FhuCBG , ,

Detailed Description

The protein FhuCBG of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 6

Sequestration of human SLC39A14 substrates/drugs in the health condition [28] , [29] , [4]

Regulating Factor

fhuD1

Detailed Description

The protein fhuD1 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 7

Sequestration of human SLC39A14 substrates/drugs in the health condition [28] , [29] , [4]

Regulating Factor

fhud2

Detailed Description

The protein fhud2 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 8

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [30] , [4]

Regulating Factor

fhud2

Detailed Description

The protein fhud2 of Staphylococcus aureus RN2564 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 9

Co-transport of human SLC39A14 substrates/drugs in the health condition [28] , [31] , [3] , [4]

Regulating Factor

HtsABC , ,

Detailed Description

The protein HtsABC of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 10

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [32] , [3] , [4]

Regulating Factor

isdA

Detailed Description

The protein isdA of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 11

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [33] , [3] , [4]

Regulating Factor

isdA

Detailed Description

The protein isdA of Staphylococcus aureus BB has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 12

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [34] , [3] , [4]

Regulating Factor

isdA

Detailed Description

The protein isdA of Staphylococcus aureus N100 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 13

Co-transport of human SLC39A14 substrates/drugs in the health condition [35] , [36] , [37] , [4]

Regulating Factor

MntABC , ,

Detailed Description

The protein MntABC of Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 14

Sequestration of human SLC39A14 substrates/drugs in the health condition [28] , [31] , [3] , [4]

Regulating Factor

SfaABC , ,

Detailed Description

The protein SfaABC of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 15

Co-transport of human SLC39A14 substrates/drugs in the health condition [28] , [38] , [3] , [4]

Regulating Factor

SirABC , ,

Detailed Description

The protein SirABC of Staphylococcus aureus subsp. aureus RN4220 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 16

Co-transport of human SLC39A14 substrates/drugs in the health condition [28] , [39] , [3] , [4]

Regulating Factor

SstABCD , , ,

Detailed Description

The protein SstABCD of Staphylococcus aureus W has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

     Staphylococcus epidermidis 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [6] , [33] , [3] , [4]

Regulating Factor

Tpn

Detailed Description

The protein tpn of Staphylococcus epidermidis 138 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [34] , [3] , [4]

Regulating Factor

Tpn

Detailed Description

The protein tpn of Staphylococcus epidermidis 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Streptococcus

     Streptococcus agalactiae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [40] , [4]

Regulating Factor

FhuCDB , ,

Detailed Description

The protein FhuCDB of Streptococcus agalactiae A909 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

     Streptococcus equi 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in upper and lower airway disease condition [16] , [41] , [4]

Regulating Factor

mtsB

Studied Phenotype

Upper and lower airway disease [ICD11: CA22]

Studied Tissue

Lung

In Vivo Model

Swiss Webster mice

Detailed Description

The protein mtsB of Streptococcus equi subsp. equi NCTC 9682 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [16] , [41] , [4]

Regulating Factor

mtsB

Detailed Description

The protein mtsB of Streptococcus equi subsp. zooepidemicus NCTC 7023T has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Streptococcus gordonii 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [35] , [36] , [42]

Regulating Factor

AdcRCBA , , ,

Detailed Description

The protein AdcRCBA of Streptococcus gordonii str. Challis has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

     Streptococcus pneumoniae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [43]

Regulating Factor

AdcCBA , ,

Detailed Description

The protein AdcCBA of Streptococcus pneumoniae D39 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

     Streptococcus suis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in sepsis condition [35] , [44] , [4]

Regulating Factor

troA

Studied Phenotype

Sepsis [ICD11: 1G40-1G41]

Studied Tissue

Liver

In Vivo Model

CD-1 mice

Detailed Description

The protein troA of Streptococcus suis serotype 9 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

Bacteria: Campylobacterota

   Genus: Campylobacter

     Campylobacter coli 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [45] , [46] , [47]

Regulating Factor

cfrB

Detailed Description

The protein cfrB of Campylobacter coli W13A has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Campylobacter jejuni 

Microbe Info

Click to Show/Hide the Full List 6 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in gastroenteritis condition [15] , [48] , [49] , [18]

Regulating Factor

znuA

Studied Phenotype

Gastroenteritis [ICD11: 1A40]

Studied Tissue

Jejunum

In Vivo Model

Chicken

Detailed Description

The protein znuA of Campylobacter jejuni subsp. jejuni 81-176 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [45] , [46] , [50]

Regulating Factor

cfrA

Detailed Description

The protein cfrA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [45] , [46] , [47]

Regulating Factor

cfrB

Detailed Description

The protein cfrB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [45] , [46] , [51]

Regulating Factor

ctuA

Detailed Description

The protein ctuA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Co-transport of human SLC39A14 substrates/drugs in the health condition [45] , [46] , [52] , [4]

Regulating Factor

feoB

Detailed Description

The protein feoB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 6

Sequestration of human SLC39A14 substrates/drugs in the health condition [45] , [53] , [4]

Regulating Factor

p19

Detailed Description

The protein p19 of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

Bacteria: Cyanobacteriota

   Genus: Synechocystis

     Synechocystis sp. PCC 6803 

Microbe Info

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [54] , [55] , [4]

Regulating Factor

futA1

Detailed Description

The protein futa1 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [54] , [55] , [4]

Regulating Factor

futA2

Detailed Description

The protein futa2 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [54] , [55] , [4]

Regulating Factor

futB

Detailed Description

The protein futb of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [54] , [56] , [4]

Regulating Factor

sll1878

Detailed Description

The protein sll1878 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

Bacteria: Pseudomonadota

   Genus: Achromobacter

     Achromobacter xylosoxidans 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [3] , [4]

Regulating Factor

Alcaligin

Detailed Description

The compound Alcaligin Secreted by Achromobacter xylosoxidans subsp. xylosoxydans KN 3-1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Acinetobacter

     Acinetobacter baumannii 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [57] , [3] , [4]

Regulating Factor

tonB3

Detailed Description

The protein tonB3 of Acinetobacter baumannii ATCC 19606 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [58] , [18]

Regulating Factor

ZnuABC , ,

Detailed Description

The protein ZnuABC of Acinetobacter baumannii ATCC 17978 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Bordetella

     Bordetella bronchiseptica 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [59] , [3] , [4]

Regulating Factor

Alcaligin

Detailed Description

The compound Alcaligin Secreted by Bordetella bronchiseptica B013N has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Bordetella pertussis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [59] , [3] , [4]

Regulating Factor

Alcaligin

Detailed Description

The compound Alcaligin Secreted by Bordetella pertussis UT25 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Bradyrhizobium

     Bradyrhizobium diazoefficiens 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [35] , [60] , [4]

Regulating Factor

mnoP

Detailed Description

The protein mnoP of Bradyrhizobium diazoefficiens USDA 110 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Brucella

     Brucella abortus 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [61] , [18]

Regulating Factor

znuA

Studied Tissue

Cervix

In Vivo Model

BALB/c athymic Nu/Nu mice

In Vitro Model

Human human papillomavirus-related endocervical adenocarcinoma cells (HeLa)

Detailed Description

The protein znua of Brucella abortus 544 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Burkholderia

     Burkholderia cepacia 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [62] , [3] , [4]

Regulating Factor

Cepabactin

Detailed Description

The compound Cepabactin Secreted by Burkholderia cepacia ATCC 25416 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [63] , [3] , [4]

Regulating Factor

Ornibactin

Detailed Description

The compound Ornibactin Secreted by Burkholderia cepacia TVV69 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [64] , [3] , [4]

Regulating Factor

Salicylic acid

Detailed Description

The compound Salicylic acid Secreted by Burkholderia cepacia Pc275c has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 19 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [65] , [3] , [4]

Regulating Factor

Aerobactin

Detailed Description

The compound Aerobactin Secreted by Escherichia coli LG1315 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [66] , [3] , [4]

Regulating Factor

Enterobactin

Detailed Description

The compound Enterobactin Secreted by Escherichia coli BW25113 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [65] , [3] , [4]

Regulating Factor

Enterobactin

Detailed Description

The compound Enterobactin Secreted by Escherichia coli str. K-12 substr. W3110 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [67] , [3] , [4]

Regulating Factor

Enterobactin

Detailed Description

The compound enterobactin secreted by Escherichia coli 9.0111 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [68] , [3] , [4]

Regulating Factor

Enterobactin

Detailed Description

The compound Enterobactin Secreted by Escherichia coli AB33II has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 6

Sequestration of human SLC39A14 substrates/drugs in the health condition [54] , [69] , [3] , [4]

Regulating Factor

efeO

Detailed Description

The protein efeO of Escherichia coli Nissle 1917 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 7

Co-transport of human SLC39A14 substrates/drugs in the health condition [54] , [70] , [4]

Regulating Factor

efeU

Detailed Description

The protein efeU of Escherichia coli O157:H7 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 8

Co-transport of human SLC39A14 substrates/drugs in the health condition [54] , [69] , [4]

Regulating Factor

efeU

Detailed Description

The protein efeU of Escherichia coli Nissle 1917 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 9

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [71] , [4]

Regulating Factor

fecA

Detailed Description

The protein fecA of Escherichia coli UT5600 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 10

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [72] , [4]

Regulating Factor

feoA

Detailed Description

The protein feoA of Escherichia coli str. K-12 substr. MC4100 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 11

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [72] , [4]

Regulating Factor

feoB

Detailed Description

The protein feoB of Escherichia coli str. K-12 substr. MC4100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 12

Co-transport of human SLC39A14 substrates/drugs in the health condition [73] , [74] , [4]

Regulating Factor

fhuA

Detailed Description

The protein fhuA of Escherichia coli K-12 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 13

Co-transport of human SLC39A14 substrates/drugs in the health condition [73] , [75] , [4]

Regulating Factor

fhuB

Detailed Description

The protein fhuB of Escherichia coli DH5[alpha] has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 14

Co-transport of human SLC39A14 substrates/drugs in the health condition [73] , [76] , [4]

Regulating Factor

fhuC

Detailed Description

The protein fhuC of Escherichia coli AB2847 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 15

Sequestration of human SLC39A14 substrates/drugs in the health condition [73] , [77] , [4]

Regulating Factor

fhuD

Detailed Description

The protein fhuD of Escherichia coli BL21(DE3) has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 16

Co-transport of human SLC39A14 substrates/drugs in the health condition [78] , [4]

Regulating Factor

IroA , , , ,

Detailed Description

The protein IroA of Escherichia coli CFT073 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 17

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [79] , [3] , [4]

Regulating Factor

iroN

Detailed Description

The protein iroN of Escherichia coli O18:H7 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 18

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [80] , [18]

Regulating Factor

ZnuABC , ,

Detailed Description

The protein ZnuABC of Escherichia coli SB2847 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 19

Up regulating of SLC39A14 expression in the health condition [18] , [81]

Regulating Factor

Lipopolysaccharide

Studied Tissue

Liver

In Vivo Model

CD-1 mice

Detailed Description

The compound Lipopolysaccharide Generated by Escherichia coli O55 has been reported to increase the expression of the drug transporter SLC39A14.

   Genus: Haemophilus

     Haemophilus influenzae 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [82] , [4]

Regulating Factor

FhuCDB , ,

Detailed Description

The protein FhuCDB of Haemophilus influenzae R2866 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [33] , [83]

Regulating Factor

tbpA

Detailed Description

The protein tbpA of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [33] , [83]

Regulating Factor

tbpB

Detailed Description

The protein tbpB of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     [Haemophilus] ducreyi 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [16] , [18] , [84]

Regulating Factor

znuA

Detailed Description

The protein znuA of [Haemophilus] ducreyi 35000HP has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Klebsiella

     Klebsiella pneumoniae 

Microbe Info

Click to Show/Hide the Full List 6 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in pneumonia condition [1] , [85] , [3] , [4]

Regulating Factor

Yersiniabactin

Studied Phenotype

Pneumonia [ICD11: CA40]

Studied Tissue

Lung

In Vivo Model

C57BL/6 mice

Detailed Description

The compound Yersiniabactin Secreted by Klebsiella pneumoniae ATCC 43816 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in lung adenocarcinoma condition [1] , [86] , [3] , [4]

Regulating Factor

Salmochelin SX

Studied Phenotype

Lung cancer [ICD11: 2C25]

Studied Tissue

Lung

In Vitro Model

Human lung adenocarcinoma cells (A549)

Detailed Description

The compound Salmochelin SX Secreted by Klebsiella pneumoniae KP20 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [87] , [3] , [4]

Regulating Factor

Salmochelin SX

Studied Tissue

Lung

In Vivo Model

C57BL/6 mice

Detailed Description

The compound Salmochelin SX Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [87] , [3] , [4]

Regulating Factor

Yersiniabactin

Studied Tissue

Lung

In Vivo Model

C57BL/6 mice

Detailed Description

The compound Yersiniabactin Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [88] , [3] , [4]

Regulating Factor

Enterobactin

Detailed Description

The compound Enterobactin Secreted by Klebsiella pneumoniae 298/53 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 6

Co-transport of human SLC39A14 substrates/drugs in the health condition [54] , [89] , [4]

Regulating Factor

feoC

Detailed Description

The protein feoc of Klebsiella pneumoniae has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Moraxella

     Moraxella catarrhalis 

Microbe Info

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [90] , [3] , [4]

Regulating Factor

lbpA

Detailed Description

The protein lbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [90] , [3] , [4]

Regulating Factor

lbpB

Detailed Description

The protein lbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [90] , [3] , [4]

Regulating Factor

tbpA

Detailed Description

The protein tbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [90] , [3] , [4]

Regulating Factor

tbpB

Detailed Description

The protein tbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Morganella

     Morganella morganii 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

2-Oxoadipic acid

Detailed Description

The compound 2-Oxoadipic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

3-Methyl-2-oxobutanoic acid

Detailed Description

The compound 3-Methyl-2-oxobutanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

4-Methyl-2-oxopentanoic acid

Detailed Description

The compound 4-Methyl-2-oxopentanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Indole-3-pyruvic acid

Detailed Description

The compound Indole-3-pyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Phenylpyruvic acid

Detailed Description

The compound Phenylpyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Neisseria

     Neisseria gonorrhoeae 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [92] , [3] , [4]

Regulating Factor

lbpA

Detailed Description

The protein lbpA of Neisseria gonorrhoeae FA19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [33] , [83]

Regulating Factor

tbpA

Detailed Description

The protein tbpa of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [33] , [83]

Regulating Factor

tbpB

Detailed Description

The protein tbpb of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Neisseria meningitidis 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in bacterial meningitis condition [15] , [18] , [93]

Regulating Factor

ZnuD

Studied Phenotype

Bacterial meningitis [ICD11: 1D01.0]

Studied Tissue

Brain

In Vivo Model

C57BL/6 mice

Detailed Description

The protein ZnuD of Neisseria meningitidis B16B6 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [33] , [83]

Regulating Factor

tbp1

Detailed Description

The protein tbp1 of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [3] , [4] , [6] , [33] , [83]

Regulating Factor

tbpB

Detailed Description

The protein tbpb of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Pasteurella

     Pasteurella multocida 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [94]

Regulating Factor

ZnuABC , ,

Studied Tissue

Intestine

In Vivo Model

Swiss mice

Detailed Description

The protein ZnuABC of Pasteurella multocida PM25 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Proteus

     Proteus mirabilis 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

2-Oxoadipic acid

Detailed Description

The compound 2-Oxoadipic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

3-Methyl-2-oxobutanoic acid

Detailed Description

The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

4-Methyl-2-oxopentanoic acid

Detailed Description

The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Indole-3-pyruvic acid

Detailed Description

The compound Indole-3-pyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Phenylpyruvic acid

Detailed Description

The compound Phenylpyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Proteus penneri 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

2-Oxoadipic acid

Detailed Description

The compound 2-oxoadipic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

3-Methyl-2-oxobutanoic acid

Detailed Description

The compound 3-methyl-2-oxobutanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

4-Methyl-2-oxopentanoic acid

Detailed Description

The compound 4-methyl-2-oxopentanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Indole-3-pyruvic acid

Detailed Description

The compound indole-3-pyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Phenylpyruvic acid

Detailed Description

The compound phenylpyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Proteus vulgaris 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

2-Oxoadipic acid

Detailed Description

The compound 2-Oxoadipic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

3-Methyl-2-oxobutanoic acid

Detailed Description

The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

4-Methyl-2-oxopentanoic acid

Detailed Description

The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Indole-3-pyruvic acid

Detailed Description

The compound Indole-3-pyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Phenylpyruvic acid

Detailed Description

The compound Phenylpyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Providencia

     Providencia alcalifaciens 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

2-Oxoadipic acid

Detailed Description

The compound 2-oxoadipic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

3-Methyl-2-oxobutanoic acid

Detailed Description

The compound 3-methyl-2-oxobutanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

4-Methyl-2-oxopentanoic acid

Detailed Description

The compound 4-methyl-2-oxopentanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Indole-3-pyruvic acid

Detailed Description

The compound indole-3-pyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Phenylpyruvic acid

Detailed Description

The compound phenylpyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Providencia rustigianii 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

2-Oxoadipic acid

Detailed Description

The compound 2-oxoadipic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

3-Methyl-2-oxobutanoic acid

Detailed Description

The compound 3-methyl-2-oxobutanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

4-Methyl-2-oxopentanoic acid

Detailed Description

The compound 4-methyl-2-oxopentanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Indole-3-pyruvic acid

Detailed Description

The compound indole-3-pyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Phenylpyruvic acid

Detailed Description

The compound phenylpyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Providencia stuartii 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

2-Oxoadipic acid

Detailed Description

The compound 2-oxoadipic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

3-Methyl-2-oxobutanoic acid

Detailed Description

The compound 3-methyl-2-oxobutanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

4-Methyl-2-oxopentanoic acid

Detailed Description

The compound 4-methyl-2-oxopentanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Indole-3-pyruvic acid

Detailed Description

The compound indole-3-pyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [91] , [3] , [4]

Regulating Factor

Phenylpyruvic acid

Detailed Description

The compound phenylpyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Pseudomonas

     Pseudomonas aeruginosa 

Microbe Info

Click to Show/Hide the Full List 6 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in cystic fibrosis condition [95] , [3] , [4]

Regulating Factor

Pyochelin

Studied Phenotype

Cystic fibrosis [ICD11: CA25]

Studied Tissue

Lung

In Vivo Model

CD-1 mice

Detailed Description

The compound Pyochelin Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in cystic fibrosis condition [95] , [3] , [4]

Regulating Factor

Pyoverdine F-Iib

Studied Phenotype

Cystic fibrosis [ICD11: CA25]

Studied Tissue

Lung

In Vivo Model

CD-1 mice

Detailed Description

The compound Pyoverdine F-Iib Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [96] , [3] , [4]

Regulating Factor

Pyochelin

Detailed Description

The compound Pyochelin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [97] , [3] , [4]

Regulating Factor

Pyoverdin

Detailed Description

The compound Pyoverdin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [98] , [3] , [4]

Regulating Factor

tonB

Detailed Description

The protein tonB of Pseudomonas aeruginosa K199 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 6

Sequestration of human SLC39A14 substrates/drugs in the health condition [99] , [3] , [4]

Regulating Factor

TonB1

Detailed Description

The protein TonB1 of Pseudomonas aeruginosa K1040 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Salmonella

     Salmonella enterica 

Microbe Info

Click to Show/Hide the Full List 17 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [100] , [3] , [4]

Regulating Factor

Enterobactin

Studied Tissue

Intestine

In Vivo Model

C3H/HeOuJ mice

Detailed Description

The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [100] , [3] , [4]

Regulating Factor

Salmochelin SX

Studied Tissue

Intestine

In Vivo Model

C3H/HeOuJ mice

Detailed Description

The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [101] , [3] , [4]

Regulating Factor

Enterobactin

Detailed Description

The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [102] , [4]

Regulating Factor

Ferrioxamine B

Detailed Description

The compound Ferrioxamine B Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [102] , [4]

Regulating Factor

Ferrioxamine E

Detailed Description

The compound Ferrioxamine E Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 6

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [102] , [4]

Regulating Factor

Ferrioxamine G1

Detailed Description

The compound Ferrioxamine G1 Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 7

Sequestration of human SLC39A14 substrates/drugs in the health condition [13] , [103] , [3] , [4]

Regulating Factor

Salmochelin SX

Detailed Description

The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 8

Sequestration of human SLC39A14 substrates/drugs in colon cancer condition [15] , [18] , [104]

Regulating Factor

znuA

Studied Phenotype

Colon cancer [ICD11: 2B90]

Studied Tissue

Colon

In Vitro Model

Human colon adenocarcinoma cells (Caco-2)

Detailed Description

The protein znuA of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 9

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [100] , [3] , [4]

Regulating Factor

fepD

Studied Tissue

Intestine

In Vivo Model

C3H/HeOuJ mice

Detailed Description

The protein fepD of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 10

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [105]

Regulating Factor

ZnuABC , ,

Studied Tissue

Intestine

In Vivo Model

C57BL/6 mice

Detailed Description

The protein ZnuABC of Salmonella enterica subsp. enterica serovar Typhimurium IR715 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 11

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [106]

Regulating Factor

ZnuABC , ,

Studied Tissue

Blood

In Vivo Model

BALB/c mice

Detailed Description

The protein ZnuABC of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 12

Co-transport of human SLC39A14 substrates/drugs in the health condition [54] , [107] , [4]

Regulating Factor

feoA

Detailed Description

The protein feoA of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 13

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [108] , [4]

Regulating Factor

feoB

Detailed Description

The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 14

Sequestration of human SLC39A14 substrates/drugs in the health condition [54] , [107] , [4]

Regulating Factor

feoB

Detailed Description

The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 15

Co-transport of human SLC39A14 substrates/drugs in the health condition [54] , [107] , [4]

Regulating Factor

feoC

Detailed Description

The protein feoC of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 16

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [100] , [4]

Regulating Factor

SitABCD , , ,

Detailed Description

The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium JF2043 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 17

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [108] , [3] , [4]

Regulating Factor

tonB

Detailed Description

The protein tonB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Serratia

     Serratia marcescens 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [54] , [55] , [109] , [4]

Regulating Factor

sfuA

Detailed Description

The protein sfua of Serratia marcescens has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in the health condition [54] , [55] , [109] , [4]

Regulating Factor

sfuB

Detailed Description

The protein sfub of Serratia marcescens has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 3

Co-transport of human SLC39A14 substrates/drugs in the health condition [54] , [55] , [109] , [4]

Regulating Factor

sfuC

Detailed Description

The protein sfuc of Serratia marcescens has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Shigella

     Shigella flexneri 

Microbe Info

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [110] , [4]

Regulating Factor

fec

Detailed Description

The protein fec of Shigella flexneri 2a has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [111] , [4]

Regulating Factor

feoB

Detailed Description

The protein feoB of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 3

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [111] , [4]

Regulating Factor

sitA

Detailed Description

The protein sitA of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 4

Co-transport of human SLC39A14 substrates/drugs in the health condition [35] , [36] , [111] , [4]

Regulating Factor

SitABCD , , ,

Detailed Description

The protein SitABCD of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

     Shigella sonnei 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [88] , [3] , [4]

Regulating Factor

Enterobactin

Detailed Description

The compound Enterobactin Secreted by Shigella sonnei 43-GG9 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

   Genus: Vibrio

     Vibrio anguillarum 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [112] , [3] , [4]

Regulating Factor

Anguibactin

Detailed Description

The compound anguibactin secreted by Vibrio anguillarum 775 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in the health condition [5] , [112] , [4]

Regulating Factor

fatA

Detailed Description

The protein fata of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 3

Co-transport of human SLC39A14 substrates/drugs in the health condition [5] , [112] , [4]

Regulating Factor

fatB

Detailed Description

The protein fatb of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

     Vibrio cholerae 

Microbe Info

Click to Show/Hide the Full List 6 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [113] , [3] , [4]

Regulating Factor

Vibriobactin

Detailed Description

The compound Vibriobactin Secreted by Vibrio cholerae Lou15 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [114] , [3] , [4]

Regulating Factor

Vibriobactin

Detailed Description

The compound Vibriobactin Secreted by Vibrio cholerae MBG14 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Co-transport of human SLC39A14 substrates/drugs in cholera condition [15] , [18] , [115]

Regulating Factor

ZnuABC , ,

Studied Phenotype

Cholera [ICD11: 1A00]

Studied Tissue

Small intestine

In Vivo Model

CD-1 mice

Detailed Description

The protein ZnuABC of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 4

Co-transport of human SLC39A14 substrates/drugs in cholera condition [15] , [18] , [115]

Regulating Factor

ZrgABCDE , , , ,

Studied Phenotype

Cholera [ICD11: 1A00]

Studied Tissue

Small intestine

In Vivo Model

CD-1 mice

Detailed Description

The protein ZrgABCDE of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 5

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [116] , [4]

Regulating Factor

Fbp

Detailed Description

The protein Fbp of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 6

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [116] , [4]

Regulating Factor

feo

Detailed Description

The protein feo of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Yersinia

     Yersinia enterocolitica 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [117] , [3] , [4]

Regulating Factor

Yersiniabactin

Detailed Description

The compound Yersiniabactin Secreted by Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [117] , [4]

Regulating Factor

fyuA

Detailed Description

The protein fyuA of Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

     Yersinia pestis 

Microbe Info

Click to Show/Hide the Full List 8 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [5] , [118] , [3] , [4]

Regulating Factor

Yersiniabactin

Detailed Description

The compound Yersiniabactin Secreted by Yersinia pestis Yreka F1+VW+P1+P+ has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in septicemic plague condition [15] , [18] , [119]

Regulating Factor

ZnuABC , ,

Studied Phenotype

Septicemic plague [ICD11: 1B93]

Studied Tissue

Blood

In Vivo Model

Swiss Webster mice

Detailed Description

The protein ZnuABC of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 3

Co-transport of human SLC39A14 substrates/drugs in pneumonic plague condition [120] , [4]

Regulating Factor

feo

Studied Phenotype

Pneumonic plague [ICD11: 1B93.2]

Studied Tissue

Lung

In Vivo Model

Swiss Webster mice

Detailed Description

The protein feo of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 4

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [121] , [3] , [4]

Regulating Factor

irp2

Studied Tissue

Lung

In Vivo Model

Swiss Webster mice

Detailed Description

The protein irp2 of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 5

Sequestration of human SLC39A14 substrates/drugs in the health condition [10] , [121] , [4]

Regulating Factor

psn

Studied Tissue

Lung

In Vivo Model

Swiss Webster mice

Detailed Description

The protein psn of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 6

Co-transport of human SLC39A14 substrates/drugs in the health condition [10] , [122] , [4]

Regulating Factor

YfeAB ,

Studied Tissue

Blood

In Vivo Model

Swiss Webster mice

Detailed Description

The protein YfeAB of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 7

Co-transport of human SLC39A14 substrates/drugs in the health condition [120] , [4]

Regulating Factor

YfeABCD , , ,

Studied Tissue

Lung

In Vivo Model

Swiss Webster mice

Detailed Description

The protein YfeABCD of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 8

Co-transport of human SLC39A14 substrates/drugs in the health condition [35] , [36] , [122] , [4]

Regulating Factor

YfeABCD , , ,

Detailed Description

The protein YfeABCD of Yersinia pestis KIM5-2031.11+ has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

     Yersinia pseudotuberculosis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [123] , [4]

Regulating Factor

tssS

Detailed Description

The protein tssS of Yersinia pseudotuberculosis YPIII has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

Bacteria: Spirochaetota

   Genus: Treponema

     Treponema pallidum 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [124] , [4]

Regulating Factor

troA

Detailed Description

The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 2

Sequestration of human SLC39A14 substrates/drugs in the health condition [124] , [3] , [4]

Regulating Factor

troA

Detailed Description

The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

       Microbe Influence 3

Sequestration of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [124]

Regulating Factor

troA

Detailed Description

The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.

Fungi: Ascomycota

   Genus: Aspergillus

     Aspergillus fumigatus 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [125] , [126] , [127]

Regulating Factor

zrfA

Detailed Description

The protein zrfA of Aspergillus fumigatus CETC has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [125] , [126] , [127]

Regulating Factor

zrfB

Detailed Description

The protein zrfB of Aspergillus fumigatus CETC has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 3

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [18] , [125] , [126] , [128]

Regulating Factor

zrfC

Detailed Description

The protein zrfC of Aspergillus fumigatus CEA17 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

   Genus: Candida

     Candida albicans 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [87] , [3] , [4]

Regulating Factor

Sit1p

Studied Tissue

Blood

In Vivo Model

BALB/c mice

Detailed Description

The protein Sit1p of Candida albicans CAF2-1 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 2

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [129] , [4]

Regulating Factor

CaFTR1

Detailed Description

The protein caftr1 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 3

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [130] , [18]

Regulating Factor

ZRT1

Detailed Description

The protein zrt1 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 4

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [125] , [131] , [18]

Regulating Factor

ZRT1

Detailed Description

The protein ZRT1 of Candida albicans M134 has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 5

Co-transport of human SLC39A14 substrates/drugs in the health condition [15] , [130] , [18]

Regulating Factor

ZRT2

Detailed Description

The protein zrt2 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A14, which affects the distribution of its substrate/drug in vivo.

Fungi: Mucoromycota

   Genus: Rhizopus

     Rhizopus microsporus 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Sequestration of human SLC39A14 substrates/drugs in the health condition [1] , [132] , [3] , [4]

Regulating Factor

Rhizoferrin

Detailed Description

The compound rhizoferrin secreted by Rhizopus microsporus has been reported to sequester the substrate/drug of SLC39A14, which may affects its substrate/drug distribution in the body.
References
1 The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat Rev Microbiol. 2017 Oct 12;15(11):675-687.
2 Purification and structural characterization of siderophore (corynebactin) from Corynebacterium diphtheriae. PLoS One. 2012;7(4):e34591.
3 Iron, copper, zinc, and manganese transport and regulation in pathogenic Enterobacteria: correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence. Front Cell Infect Microbiol. 2013 Dec 5;3:90.
4 Iron and manganese transport in mammalian systems. Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118890.
5 Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 2000;54:881-941.
6 Mycobacterium tuberculosis acquires iron by cell-surface sequestration and internalization of human holo-transferrin. Nat Commun. 2014 Aug 28;5:4730.
7 Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med. 1996 Apr 1;183(4):1527-32.
8 The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. J Bacteriol. 2010 Feb;192(3):861-9.
9 Iron uptake processes in Mycobacterium vaccae R877R, a mycobacterium lacking mycobactin. J Gen Microbiol. 1986 Mar;132(3):845-52.
10 Sequestration and scavenging of iron in infection. Infect Immun. 2013 Oct;81(10):3503-14.
11 IlsA, a unique surface protein of Bacillus cereus required for iron acquisition from heme, hemoglobin and ferritin. PLoS Pathog. 2009 Nov;5(11):e1000675.
12 Siderophores of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Biochem Biophys Res Commun. 2006 Sep 15;348(1):320-5.
13 The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 2010 Aug 12;6(8):e1000949.
14 Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18499-503.
15 Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect Microbiol. 2014 Jan 24;4:2.
16 A new family of high-affinity ABC manganese and zinc permeases. Res Microbiol. 2001 Apr-May;152(3-4):231-43.
17 Identification of a zinc-specific metalloregulatory protein, Zur, controlling zinc transport operons in Bacillus subtilis. J Bacteriol. 1998 Nov;180(22):5815-21.
18 Transition metals and host-microbe interactions in the inflamed intestine. Biometals. 2019 Jun;32(3):369-384.
19 Metallobiology of Lactobacillaceae in the gut microbiome. J Inorg Biochem. 2023 Jan;238:112023.
20 The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 2001 May;11(5):731-53.
21 Two zinc uptake systems contribute to the full virulence of Listeria monocytogenes during growth in vitro and in vivo. Infect Immun. 2012 Jan;80(1):14-21.
22 Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun. 1997 May;65(5):1944-8.
23 Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A. Biochemistry. 2009 Feb 10;48(5):1025-35.
24 Biosynthesis of a broad-spectrum nicotianamine-like metallophore in Staphylococcus aureus. Science. 2016 May 27;352(6289):1105-9.
25 Competitors versus Collaborators: Micronutrient Processing by Pathogenic and Commensal Human-Associated Gut Bacteria. Mol Cell. 2020 May 21;78(4):570-576.
26 Bacterial Strategies to Maintain Zinc Metallostasis at the Host-Pathogen Interface. J Biol Chem. 2016 Sep 30;291(40):20858-20868.
27 A metal-ligand-mediated intersubunit allosteric switch in related SmtB/ArsR zinc sensor proteins. J Mol Biol. 2003 Oct 31;333(4):683-95.
28 Siderophore-mediated iron acquisition in the staphylococci. J Inorg Biochem. 2010 Mar;104(3):282-8.
29 FhuD1, a ferric hydroxamate-binding lipoprotein in Staphylococcus aureus: a case of gene duplication and lateral transfer. J Biol Chem. 2004 Dec 17;279(51):53152-9.
30 The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus. Demonstration that FhuD2 binds iron(III)-hydroxamates but with minimal conformational change and implication of mutations on transport. J Biol Chem. 2003 Dec 12;278(50):49890-900.
31 Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol Microbiol. 2009 May;72(4):947-63.
32 Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein. Mol Microbiol. 2002 Mar;43(6):1603-14.
33 The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun. 1999 Mar;67(3):1086-92.
34 Staphylococci express a receptor for human transferrin: identification of a 42-kilodalton cell wall transferrin-binding protein. Infect Immun. 1994 Sep;62(9):3850-8.
35 Manganese homeostasis and utilization in pathogenic bacteria. Mol Microbiol. 2015 Jul;97(2):216-28.
36 Manganese transport and the role of manganese in virulence. Annu Rev Microbiol. 2006;60:187-209.
37 MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. Mol Microbiol. 2002 Jun;44(5):1269-86.
38 Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. J Bacteriol. 2004 Dec;186(24):8356-62.
39 Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus. Infect Immun. 2000 Nov;68(11):6281-8.
40 Evidence for siderophore-dependent iron acquisition in group B streptococcus. Mol Microbiol. 2006 Jan;59(2):707-21.
41 Identification of lipoprotein homologues of pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus. Infect Immun. 2000 Oct;68(10):6048-51.
42 Involvement of the adc operon and manganese homeostasis in Streptococcus gordonii biofilm formation. J Bacteriol. 2003 May;185(9):2887-900.
43 Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol Microbiol. 1997 Aug;25(4):727-39.
44 TroA of Streptococcus suis is required for manganese acquisition and full virulence. J Bacteriol. 2011 Oct;193(19):5073-80.
45 Metal homeostasis in pathogenic Epsilonproteobacteria: mechanisms of acquisition, efflux, and regulation. Metallomics. 2021 Jan 16;13(1):mfaa002.
46 Nutrient acquisition and metabolism by Campylobacter jejuni. Front Cell Infect Microbiol. 2012 Feb 7;2:5.
47 Identification and characterization of a new ferric enterobactin receptor, CfrB, in Campylobacter. J Bacteriol. 2010 Sep;192(17):4425-35.
48 A Campylobacter jejuni znuA orthologue is essential for growth in low-zinc environments and chick colonization. J Bacteriol. 2009 Mar;191(5):1631-40.
49 Zinc competition among the intestinal microbiota. mBio. 2012 Jul 31;3(4):e00171-12.
50 Iron acquisition and regulation in Campylobacter jejuni. J Bacteriol. 2004 Jul;186(14):4714-29.
51 Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni. J Bacteriol. 2008 Mar;190(6):1900-11.
52 Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun. 2006 Oct;74(10):5433-44.
53 Structure and function of P19, a high-affinity iron transporter of the human pathogen Campylobacter jejuni. J Mol Biol. 2010 Aug 27;401(4):590-604.
54 Bacterial ferrous iron transport: the Feo system. FEMS Microbiol Rev. 2016 Mar;40(2):273-98.
55 Iron-binding activity of FutA1 subunit of an ABC-type iron transporter in the cyanobacterium Synechocystis sp. Strain PCC 6803. Plant Cell Physiol. 2001 Aug;42(8):823-7.
56 Genes essential to iron transport in the cyanobacterium Synechocystis sp. strain PCC 6803. J Bacteriol. 2001 May;183(9):2779-84.
57 Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity. Infect Immun. 2019 Mar 25;87(4):e00755-18.
58 Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS Pathog. 2012;8(12):e1003068.
59 Purification, spectroscopic analysis and biological activity of the macrocyclic dihydroxamate siderophore alcaligin produced by Bordetella pertussis and Bordetella bronchiseptica. Biometals. 1996 Apr;9(2):191-203.
60 Bacterial outer membrane channel for divalent metal ion acquisition. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15390-5.
61 Zinc uptake system (znuA locus) of Brucella abortus is essential for intracellular survival and virulence in mice. J Vet Med Sci. 2004 Sep;66(9):1059-63.
62 Cepabactin from Pseudomonas cepacia, a new type of siderophore. J Gen Microbiol. 1989 Jun;135(6):1479-87.
63 Ornibactins--a new family of siderophores from Pseudomonas. Biometals. 1993 Summer;6(2):93-100.
64 Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol. 1992 Mar;36(3):184-9.
65 Relative availability of transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infect Immun. 1991 Sep;59(9):3185-90.
66 The alternative role of enterobactin as an oxidative stress protector allows Escherichia coli colony development. PLoS One. 2014 Jan 2;9(1):e84734.
67 Production of enterochelin by Escherichia coli 0111. Biochim Biophys Acta. 1977 Apr 27;497(2):548-57.
68 The structure of enterochelin and related 2,3-dihydroxy-N-benzoylserine conjugates from Escherichia coli. Biochim Biophys Acta. 1970 Aug 14;215(2):393-402.
69 A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli. Mol Microbiol. 2006 Oct;62(1):120-31.
70 EfeUOB (YcdNOB) is a tripartite, acid-induced and CpxAR-regulated, low-pH Fe2+ transporter that is cryptic in Escherichia coli K-12 but functional in E. coli O157:H7. Mol Microbiol. 2007 Aug;65(4):857-75.
71 Structural basis of gating by the outer membrane transporter FecA. Science. 2002 Mar 1;295(5560):1715-9.
72 Characterization of the ferrous iron uptake system of Escherichia coli. J Bacteriol. 1993 Oct;175(19):6212-9.
73 Iron uptake mechanisms and their regulation in pathogenic bacteria. Int J Med Microbiol. 2001 May;291(2):67-79.
74 Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 1998 Dec 18;282(5397):2215-20.
75 Transmembrane topology of the two FhuB domains representing the hydrophobic components of bacterial ABC transporters involved in the uptake of siderophores, haem and vitamin B12. Microbiology (Reading). 1998 Oct;144 ( Pt 10):2759-2769.
76 Iron(III) hydroxamate transport in Escherichia coli K-12: FhuB-mediated membrane association of the FhuC protein and negative complementation of fhuC mutants. J Bacteriol. 1992 Apr;174(7):2305-11.
77 The structure of the ferric siderophore binding protein FhuD complexed with gallichrome. Nat Struct Biol. 2000 Apr;7(4):287-91.
78 The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16502-7.
79 The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infect Immun. 2004 Feb;72(2):1216-20.
80 The ZnuABC high-affinity zinc uptake system and its regulator Zur in Escherichia coli. Mol Microbiol. 1998 Jun;28(6):1199-210.
81 Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6843-8.
82 Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae. BMC Microbiol. 2010 Apr 15;10:113.
83 Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol. 1994 Dec;14(5):843-50.
84 Identification of the znuA-encoded periplasmic zinc transport protein of Haemophilus ducreyi. Infect Immun. 1999 Oct;67(10):5060-8.
85 Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun. 2011 Aug;79(8):3309-16.
86 Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1alpha and proinflammatory cytokine secretion in cultured respiratory epithelial cells. Infect Immun. 2014 Sep;82(9):3826-36.
87 The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun. 2002 Sep;70(9):5246-55.
88 Siderophore synthesis in Klebsiella pneumoniae and Shigella sonnei during iron deficiency. J Bacteriol. 1979 Dec;140(3):1129-32.
89 NMR structure note: the ferrous iron transport protein C (FeoC) from Klebsiella pneumoniae. J Biomol NMR. 2012 Jun;53(2):161-5.
90 Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect. 2000 Apr;2(5):547-59.
91 Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J Bacteriol. 1993 May;175(9):2727-33.
92 Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect Immun. 1995 Aug;63(8):2958-67.
93 The molecular mechanism of Zinc acquisition by the neisserial outer-membrane transporter ZnuD. Nat Commun. 2015 Aug 18;6:7996.
94 The high-affinity zinc-uptake system znuACB is under control of the iron-uptake regulator (fur) gene in the animal pathogen Pasteurella multocida. FEMS Microbiol Lett. 2003 Apr 11;221(1):31-7.
95 Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection. Infect Immun. 2016 Jul 21;84(8):2324-2335.
96 Pyochelin: novel structure of an iron-chelating growth promoter for Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4256-60.
97 Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun. 1985 Jul;49(1):132-40.
98 The Pseudomonas aeruginosa tonB gene encodes a novel TonB protein. Microbiology (Reading). 1996 Jun;142 ( Pt 6):1449-1458.
99 Mutational analysis of the TonB1 energy coupler of Pseudomonas aeruginosa. J Bacteriol. 2002 Mar;184(6):1503-13.
100 Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol. 2008 Mar;67(5):971-83.
101 Enterobactin, an iron transport compound from Salmonella typhimurium. Biochem Biophys Res Commun. 1970 Mar 12;38(5):989-92.
102 Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica. Appl Environ Microbiol. 1999 Apr;65(4):1610-8.
103 Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3677-82.
104 Salmonella enterica serovar Typhimurium growth is inhibited by the concomitant binding of Zn(II) and a pyrrolyl-hydroxamate to ZnuA, the soluble component of the ZnuABC transporter. Biochim Biophys Acta. 2016 Mar;1860(3):534-41.
105 The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity. 2014 Feb 20;40(2):262-73.
106 Role of the high-affinity zinc uptake znuABC system in Salmonella enterica serovar typhimurium virulence. Infect Immun. 2002 Aug;70(8):4721-5.
107 Lon-mediated proteolysis of the FeoC protein prevents Salmonella enterica from accumulating the Fe(II) transporter FeoB under high-oxygen conditions. J Bacteriol. 2015 Jan 1;197(1):92-8.
108 Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse. Infect Immun. 1996 Nov;64(11):4549-56.
109 Nucleotide sequences of the sfuA, sfuB, and sfuC genes of Serratia marcescens suggest a periplasmic-binding-protein-dependent iron transport mechanism. J Bacteriol. 1990 Feb;172(2):572-8.
110 Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infect Immun. 2001 Oct;69(10):6012-21.
111 Contribution of the Shigella flexneri Sit, Iuc, and Feo iron acquisition systems to iron acquisition in vitro and in cultured cells. Infect Immun. 2003 Apr;71(4):1919-28.
112 The AngR protein and the siderophore anguibactin positively regulate the expression of iron-transport genes in Vibrio anguillarum. Mol Microbiol. 1996 Oct;22(1):127-34.
113 Cloning of a Vibrio cholerae vibriobactin gene cluster: identification of genes required for early steps in siderophore biosynthesis. J Bacteriol. 1997 Nov;179(22):7055-62.
114 Cloning, sequencing, and transcriptional regulation of viuA, the gene encoding the ferric vibriobactin receptor of Vibrio cholerae. J Bacteriol. 1992 Jun;174(11):3729-38.
115 Dual Zinc Transporter Systems in Vibrio cholerae Promote Competitive Advantages over Gut Microbiome. Infect Immun. 2015 Oct;83(10):3902-8.
116 Characterization of ferric and ferrous iron transport systems in Vibrio cholerae. J Bacteriol. 2006 Sep;188(18):6515-23.
117 Purification of yersiniabactin: a siderophore and possible virulence factor of Yersinia enterocolitica. J Gen Microbiol. 1993 Sep;139(9):2159-65.
118 Siderochrome production by Yersinia pestis and its relation to virulence. Infect Immun. 1975 Nov;12(5):1211-3.
119 The Yersinia pestis siderophore, yersiniabactin, and the ZnuABC system both contribute to zinc acquisition and the development of lethal septicaemic plague in mice. Mol Microbiol. 2014 Aug;93(4):759-75.
120 The Yfe and Feo transporters are involved in microaerobic growth and virulence of Yersinia pestis in bubonic plague. Infect Immun. 2012 Nov;80(11):3880-91.
121 The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun. 2010 May;78(5):2045-52.
122 The Yfe system of Yersinia pestis transports iron and manganese and is required for full virulence of plague. Mol Microbiol. 1999 Apr;32(2):403-14.
123 T6SS translocates a micropeptide to suppress STING-mediated innate immunity by sequestering manganese. Proc Natl Acad Sci U S A. 2021 Oct 19;118(42):e2103526118.
124 The general transition metal (Tro) and Zn2+ (Znu) transporters in Treponema pallidum: analysis of metal specificities and expression profiles. Mol Microbiol. 2007 Jul;65(1):137-52.
125 Immunological orchestration of zinc homeostasis: The battle between host mechanisms and pathogen defenses. Arch Biochem Biophys. 2016 Dec 1;611:66-78.
126 Zinc and Manganese Chelation by Neutrophil S100A8/A9 (Calprotectin) Limits Extracellular Aspergillus fumigatus Hyphal Growth and Corneal Infection. J Immunol. 2016 Jan 1;196(1):336-44.
127 The zrfA and zrfB genes of Aspergillus fumigatus encode the zinc transporter proteins of a zinc uptake system induced in an acid, zinc-depleted environment. Eukaryot Cell. 2005 May;4(5):837-48.
128 Aspergillus fumigatus survival in alkaline and extreme zinc-limiting environments relies on the induction of a zinc homeostasis system encoded by the zrfC and aspf2 genes. Eukaryot Cell. 2010 Mar;9(3):424-37.
129 A high-affinity iron permease essential for Candida albicans virulence. Science. 2000 May 12;288(5468):1062-4.
130 Zinc sequestration: arming phagocyte defense against fungal attack. PLoS Pathog. 2013;9(12):e1003815.
131 Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog. 2012;8(6):e1002777.
132 Rhizoferrin: a complexone type siderophore of the Mucorales and entomophthorales (Zygomycetes). FEMS Microbiol Lett. 1992 Jul 1;73(1-2):37-41.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.